IS5663A - A composition comprising L-carnitine or alkanoyl L-carnitine and NADH and / or NADHP - Google Patents
A composition comprising L-carnitine or alkanoyl L-carnitine and NADH and / or NADHPInfo
- Publication number
- IS5663A IS5663A IS5663A IS5663A IS5663A IS 5663 A IS5663 A IS 5663A IS 5663 A IS5663 A IS 5663A IS 5663 A IS5663 A IS 5663A IS 5663 A IS5663 A IS 5663A
- Authority
- IS
- Iceland
- Prior art keywords
- carnitine
- nadhp
- nadh
- alkanoyl
- composition
- Prior art date
Links
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 title 1
- -1 alkanoyl L-carnitine Chemical compound 0.000 title 1
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 title 1
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Psychology (AREA)
- Nutrition Science (AREA)
- Molecular Biology (AREA)
- Emergency Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT98RM000238A IT1299161B1 (en) | 1998-04-17 | 1998-04-17 | COMPOSITION INCLUDING L-CARNITINE OR AN ALCANOYL L-CARNITINE AND NADH AND / OR NADPH |
| PCT/IT1999/000088 WO1999053921A1 (en) | 1998-04-17 | 1999-04-14 | Composition comprising l-carnitine or an alkanoyl l-carnitine and nadh and/or nadph |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IS5663A true IS5663A (en) | 2000-10-13 |
Family
ID=11405812
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IS5663A IS5663A (en) | 1998-04-17 | 2000-10-13 | A composition comprising L-carnitine or alkanoyl L-carnitine and NADH and / or NADHP |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP1071424A1 (en) |
| JP (1) | JP2002512191A (en) |
| KR (1) | KR20010042765A (en) |
| CN (1) | CN1299283A (en) |
| AU (1) | AU750645B2 (en) |
| BR (1) | BR9909712A (en) |
| CA (1) | CA2328331A1 (en) |
| EE (1) | EE200000601A (en) |
| HU (1) | HUP0101914A3 (en) |
| IL (1) | IL139014A0 (en) |
| IS (1) | IS5663A (en) |
| IT (1) | IT1299161B1 (en) |
| NO (1) | NO20005128L (en) |
| PL (1) | PL343482A1 (en) |
| SK (1) | SK15442000A3 (en) |
| TR (1) | TR200002894T2 (en) |
| WO (1) | WO1999053921A1 (en) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8252309B2 (en) | 2000-04-04 | 2012-08-28 | Sigma-Tau Industrie Farmaceutiche Riunite Spa | Dietary supplement energy-providing to skeletal muscles |
| DE10326822A1 (en) * | 2003-06-11 | 2005-01-05 | Herzpharma Vita-Check Diagnosegeräte GmbH | Dietary supplement, e.g. for increasing general performance, concentration and endurance, comprises NADH, L-carnitine, coenzyme Q10, L-carnosine, succinic acid, ascorbic acid and bioflavonoids |
| AU2007353211B2 (en) * | 2007-05-11 | 2013-08-29 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Gel useful for the delivery of cosmetic active ingredients |
| WO2011022786A1 (en) * | 2009-08-31 | 2011-03-03 | Pharmaqest Pty Ltd | Methods for diagnosis and treatment of chronic fatigue syndrome |
| CN104306390A (en) * | 2014-10-23 | 2015-01-28 | 苏州人本药业有限公司 | Application of reduced coenzyme II |
| CN104840479A (en) * | 2015-02-17 | 2015-08-19 | 苏州人本药业有限公司 | Application of NADPH in preparation of drugs used for treating heart diseases |
| US10894059B2 (en) * | 2017-12-22 | 2021-01-19 | Bontac Bio-Engineering (Shenzhen) Co., Ltd | NADH compound composition, and preparation and use thereof |
| EP3755160B1 (en) | 2018-04-20 | 2021-11-03 | Pacotrade AG | Device for crushing deep-frozen foodstuffs provided in block form |
| CN109170907A (en) * | 2018-08-30 | 2019-01-11 | 泓博元生命科技(深圳)有限公司 | A kind of preparation method of composition containing NMN, application and sports drink |
| CN109105702A (en) * | 2018-08-30 | 2019-01-01 | 泓博元生命科技(深圳)有限公司 | A kind of preparation method of composition containing NADH, application and energy extender |
| JP7199518B2 (en) * | 2018-10-10 | 2023-01-05 | 蘇娥 梁 | Health care product composition for deficit compensation, method of making and use thereof |
| CN117958433A (en) * | 2024-03-22 | 2024-05-03 | 四川新渔新美健康科技有限公司 | Caffeine-free anti-fatigue functional composition and beverage |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1054698A (en) * | 1964-12-04 | |||
| US5292538A (en) * | 1992-07-22 | 1994-03-08 | Metagenics, Inc. | Improved sustained energy and anabolic composition and method of making |
| DE4335454A1 (en) * | 1993-10-19 | 1995-04-20 | Schleicher Peter | Geriatric medical composition |
| JPH09110708A (en) * | 1995-08-11 | 1997-04-28 | Taisho Pharmaceut Co Ltd | Nutritional tonic crude drug combination preparation |
| JPH0959161A (en) * | 1995-08-23 | 1997-03-04 | Taisho Pharmaceut Co Ltd | Fatigue improving composition |
| IT1277953B1 (en) * | 1995-12-21 | 1997-11-12 | Sigma Tau Ind Farmaceuti | PHARMACEUTICAL COMPOSITION CONTAINING L-CARNITINE OR AN ALCANOYL L-CARNITINE AND A 3-OMEGA SERIES POLYUNSATURED ACID USEFUL |
| IT1283951B1 (en) * | 1996-03-15 | 1998-05-07 | Mendes Srl | USE OF ACETYL L-CARNITINE OR ITS PHARMACOLOGICALLY ACCEPTABLE SALTS FOR THERAPEUTIC TREATMENT OR PROPHYLAXIS OF |
| US5712259A (en) * | 1996-04-22 | 1998-01-27 | Birkmayer Pharmaceuticals | NADH and NADPH pharmaceuticals for treating chronic fatigue syndrome |
| US6077828A (en) * | 1996-04-25 | 2000-06-20 | Abbott Laboratories | Method for the prevention and treatment of cachexia and anorexia |
| JPH10175856A (en) * | 1996-10-14 | 1998-06-30 | Taisho Pharmaceut Co Ltd | Fatigue improver |
-
1998
- 1998-04-17 IT IT98RM000238A patent/IT1299161B1/en active IP Right Grant
-
1999
- 1999-04-14 WO PCT/IT1999/000088 patent/WO1999053921A1/en not_active Ceased
- 1999-04-14 TR TR2000/02894T patent/TR200002894T2/en unknown
- 1999-04-14 CA CA002328331A patent/CA2328331A1/en not_active Abandoned
- 1999-04-14 EP EP99916039A patent/EP1071424A1/en not_active Withdrawn
- 1999-04-14 AU AU34428/99A patent/AU750645B2/en not_active Ceased
- 1999-04-14 JP JP2000544325A patent/JP2002512191A/en active Pending
- 1999-04-14 SK SK1544-2000A patent/SK15442000A3/en unknown
- 1999-04-14 PL PL99343482A patent/PL343482A1/en not_active Application Discontinuation
- 1999-04-14 HU HU0101914A patent/HUP0101914A3/en unknown
- 1999-04-14 KR KR1020007011499A patent/KR20010042765A/en not_active Withdrawn
- 1999-04-14 IL IL13901499A patent/IL139014A0/en unknown
- 1999-04-14 BR BR9909712-5A patent/BR9909712A/en not_active IP Right Cessation
- 1999-04-14 CN CN99805644A patent/CN1299283A/en active Pending
- 1999-04-14 EE EEP200000601A patent/EE200000601A/en unknown
-
2000
- 2000-10-12 NO NO20005128A patent/NO20005128L/en not_active Application Discontinuation
- 2000-10-13 IS IS5663A patent/IS5663A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR9909712A (en) | 2000-12-26 |
| HUP0101914A2 (en) | 2002-03-28 |
| ITRM980238A1 (en) | 1999-10-17 |
| IL139014A0 (en) | 2001-11-25 |
| IT1299161B1 (en) | 2000-02-29 |
| AU750645B2 (en) | 2002-07-25 |
| AU3442899A (en) | 1999-11-08 |
| SK15442000A3 (en) | 2001-06-11 |
| CN1299283A (en) | 2001-06-13 |
| PL343482A1 (en) | 2001-08-27 |
| NO20005128L (en) | 2000-12-18 |
| NO20005128D0 (en) | 2000-10-12 |
| HUP0101914A3 (en) | 2002-12-28 |
| EE200000601A (en) | 2002-04-15 |
| JP2002512191A (en) | 2002-04-23 |
| TR200002894T2 (en) | 2001-01-22 |
| CA2328331A1 (en) | 1999-10-28 |
| EP1071424A1 (en) | 2001-01-31 |
| WO1999053921A1 (en) | 1999-10-28 |
| KR20010042765A (en) | 2001-05-25 |
| ITRM980238A0 (en) | 1998-04-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69933825D1 (en) | Chemically amplified positive resist composition | |
| DE69905371D1 (en) | HARDENABLE COMPOSITION | |
| NO991151D0 (en) | Compound and Use thereof | |
| IS5850A (en) | Antioxidant composition comprising acetyl L-carnitine and alpha-lipoic acid | |
| SG79263A1 (en) | Adhesive composition and adhesive sheet | |
| HUP0104270A3 (en) | Herbicidal composition and use thereof | |
| DE69933544D1 (en) | POLYMER AND HARDENABLE COMPOSITION | |
| EP0989459A4 (en) | Chemically amplified resist composition | |
| HU9903361D0 (en) | Filter-device with collecting-vessel and with heating-device | |
| NO20006488D0 (en) | Composition and application | |
| NO20022334L (en) | New composition and application | |
| IL128869A0 (en) | Pyrozolopyrimidines and pyrazolotriazines | |
| DE69831605T2 (en) | ANTI-ESTROGEN AND PROGESTINE-CONTAINING ORAL CONTRAZEPTIVA | |
| DK1112003T3 (en) | New composition and application | |
| EP1096316A4 (en) | Positive resist composition | |
| PT1139761E (en) | HERBICID AND CONCENTRATED COMPOSITIONS | |
| DE69908455D1 (en) | inserter | |
| IL138178A0 (en) | Identifiable marking compositions and methods | |
| EP1117084A4 (en) | Music notation implement and music | |
| IS5663A (en) | A composition comprising L-carnitine or alkanoyl L-carnitine and NADH and / or NADHP | |
| EP1056455A4 (en) | Epimorphian compound and its use | |
| MA26666A1 (en) | ANTIOXIDE, ANTIPROLIFERATE COMPOSITION, INCLUDING CARNITINE AND CAROTENOIDE. | |
| GB9803232D0 (en) | Compound composition and use | |
| NO20006626D0 (en) | Coating agent and its use | |
| PL338379A1 (en) | Novel photoinitiators and their application |